Learn More
Medchemexpress LLC Avanafil | 330784-47-9 | 98.7% | 483.95 | 250 MG

Supplier: Medchemexpress LLC 250MGHY18252
Avanafil (TA-1790) is a potent and selective phosphodiesterase-5 (PDE-5) inhibitor. It activates the NO/cGMP/PKG signaling-pathway, which helps decrease bone mineral density loss, bone atrophy, and oxidative stress. Avanafil inhibits cyclic guanosine monophosphate (cGMP) hydrolysis, thereby increasing cGMP levels, making it suitable for research related to erectile dysfunction and osteoporosis.
- Potent and selective PDE-5 inhibitor
- Activates NO/cGMP/PKG signaling-pathway
- Decreases loss in bone mineral density, bone atrophy, and oxidative stress
- Increases cGMP levels by inhibiting cGMP hydrolysis
- Used in research for erectile dysfunction and osteoporosis
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.